Angina

SAN DIEGO — Renal angina indices may help predict AKI risk in patients who are critically ill and hospitalized in the ICU, according to data presented at ASN Kidney Week.

High BMI eligibility for semaglutide could cost Medicare up to $145 billion annually, a brief report published in the Annals of Internal Medicine revealed.

ATLANTA — Use of a coronary sinus reducer improved chest pain symptoms and quality of life for patients with significant coronary artery disease, despite not improving myocardial blood flow, a speaker reported.

Men with CAD taking nitrates for chest pain plus a PDE5 inhibitor for erectile dysfunction were at greater risk for death or major adverse CV events compared with men taking nitrates alone, Swedish registry data show.

PHILADELPHIA — In patients with stable angina and evidence of ischemia, PCI improved angina symptoms at 12 weeks compared with a sham procedure, according to the results from the ORBITA-2 trial.

Danish researchers reported that CT angiography-derived fractional flow reserve was significantly prognostic of all-cause death and acute MI in patients with stable angina, especially those with high coronary calcium scores.

In patients with angina with nonobstructive CAD, invasive testing increased the likelihood of an angina endotype diagnosis and improved treatment satisfaction compared with controls, but did not improve angina burden, researchers reported.

Compared with metallic drug-eluting stents, a first-generation everolimus-eluting bioresorbable vascular scaffold had similar 5-year rates of death, patient-oriented composite events, angina recurrence and quality of life, data show.

Increased change in fractional flow reserve at 3-month follow-up after PCI was moderately associated with less angina and improved quality of life, researchers reported.